Category Archives: Investment

Health-sector investors hold breath as 2018 mercifully comes to a close; but what does 2019 portend? Anyone else cringe at prime-number years?

As investors stagger toward the New Year, adjusting their neck braces for one final lap of trading on December 31, there’s one big consolation for the recent, massive, daily twists… Read more »

This Dutch biotech startup is quietly developing a novel immune-cell approach for cancer. Can it muscle in on established rivals?

The News: Lava Therapeutics BV (Hertogenbosch NLD) is quietly developing a cancer immunotherapy that arms a rare type of immune cell called gamma delta T cells, Labiotech.eu reports. The company’s… Read more »

Moderna launches biggest biotech IPO ever, but shares immediately crash. Is this a buying opportunity?

The News: Moderna Therapeutics Inc. (Cambridge MA) watched its share price nosedive within hours of pulling off the biggest initial public offering in biotech history, a sign the company and its underwriters… Read more »

Tissue engineering and regenerative medicine starting to elbow its way into media coverage; watch out you cancer “miracle cures.”

The News: A group of researchers in Spain has developed a silk biomaterial that can increase the survival of transplanted stem cells into the brain, improving recovery after a stroke… Read more »

US IPOs not done yet for 2018 as two foreigners pick Nasdaq for their maiden launch.

The News: Last week, Taiwan Liposome Co. Ltd. (TLC), which is developing lipid formulations of approved drugs for pain and eye disease, raised $22 million by offering 3.75 million ADSs… Read more »

Europe frets over waning IPO biotech scene while US pricings and new registrations keep chugging along.

The News: Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets there prompting speculation that biotech stocks are underperforming, according… Read more »

PART TWO: The future of Russian pharma. Why does China (among so many others) surpass Russia when it comes to pharma/biotech innovation?

In examining why Russia is behind its neighbor China in pharma and biotech innovation, one must keep in mind that Chinese medicine is a style of traditional treatment built on a foundation… Read more »

FDA clears psilocybin for testing as breakthrough therapy

UPDATE: FDA permits psilocybin to be tested for refractory depression; grants Breakthrough Therapy designation for magic mushrooms psychedelic compound. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy… Read more »

Europe bursts onto the biotech scene as Grifols’ Phase 2b/3 plasma replacement therapy works in Alzheimer’s patients. Buy, sell or hold?

The News: A blood plasma replacement therapy from Spanish company Grifols SA (Barcelona) reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo, Labiotech.eu reports. The… Read more »